Crossmark

Integrating US-guided FNAB, BRAFV600E mutation, and clinicopathologic characteristics to predict cervical central lymph-node metastasis in preoperative patients with cN0 papillary thyroid carcinoma

Crossref DOI link: https://doi.org/10.1007/s00405-023-08156-w

Published Online: 2023-08-04

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Ning

Tian, Hai-Ying

Yu, Zhao-Yan

Zhu, Xin

Zhao, Dai-Wei https://orcid.org/0009-0000-4668-7096
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81860478)

Guizhou Provincial Science and Technology Projects (ZK [2022] 257)
License Information

Text and Data Mining valid from 2023-08-04

Version of Record valid from 2023-08-04
More Information

Article History

Received: 15 June 2023

Accepted: 25 July 2023

First Online: 4 August 2023

Declarations

:

: This manuscript has not been published nor submitted for publication elsewhere. All authors have contributed significantly, and agree with the content of the manuscript. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

: This study has been approved by the Institutional Review Board of Guizhou Provincial People's Hospital ethics committee, and has been performed according to the ethical standards laid down in the 1964 Declaration of Helsinki.

: Due to the retrospective nature of this study, the need for informed consent was waived.

Document is current

Any future updates will be listed below